Warrenville, Illinois Clinical Trials

A listing of Warrenville, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 87 clinical trials
Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer

This randomized phase III trial studies how well paclitaxel, trastuzumab, and pertuzumab with or without atezolizumab works in treating patients with breast cancer that has spread to other parts of the body (metastatic). Chemotherapy drugs, such as paclitaxel, work in different ways to stop the growth of tumor cells, either …

monoclonal antibodies
paclitaxel
estrogen receptor
staining intensity
progesterone receptor
Rush - Copley Medical Center
 (5.9 away) Contact site
  • 445 views
  • 19 Sep, 2021
  • +459 other locations
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors Lymphomas or Multiple Myeloma (The MATCH Screening Trial)

This phase II MATCH trial studies how well treatment that is directed by genetic testing works in patients with solid tumors or lymphomas that have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists. Genetic tests look at the unique genetic …

heart failure
skin cancer
cytology specimen collection procedure
taselisib
gonadotropin releasing hormone
Rush - Copley Medical Center
 (5.9 away) Contact site
  • 6097 views
  • 19 Sep, 2021
  • +1027 other locations
Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

This randomized phase II/III trial studies docetaxel, antiandrogen therapy, and radiation therapy to see how well it works compared with antiandrogen therapy and radiation therapy alone in treating patients with prostate cancer that has been removed by surgery. Androgen can cause the growth of prostate cells. Antihormone therapy may lessen …

Edward Hospital/Cancer Center
 (5.0 away) Contact site
  • 1468 views
  • 19 Sep, 2021
  • +328 other locations
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

nivolumab
paclitaxel
pembrolizumab
squamous cell carcinoma
carcinoma
AMG Oncology - Naperville
 (5.0 away) Contact site
  • 1103 views
  • 19 Sep, 2021
  • +1140 other locations
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial enrolls participants for …

gonadotrophin releasing hormone
pheochromocytoma, malignant
squamous cell carcinoma of head and neck
parathyroid
MRI
Rush - Copley Medical Center
 (5.9 away) Contact site
  • 6048 views
  • 19 Sep, 2021
  • +817 other locations
A Phase II/III Trial of Nivolumab Ipilimumab and GM-CSF in Patients With Advanced Melanoma

This phase II/III trial studies the side effects of nivolumab and ipilimumab when given together with or without sargramostim and to see how well they work in treating patients with stage III-IV melanoma that cannot be removed by surgery (unresectable). Immunotherapy with monoclonal antibodies, such as ipilimumab and nivolumab, may …

monoclonal antibodies
advanced melanoma
immunomodulators
ipilimumab
nitrosoureas
Rush - Copley Medical Center
 (5.1 away) Contact site
  • 46 views
  • 08 Sep, 2021
  • +436 other locations
Study of Efficacy Safety and Tolerability of LYS006 in Patients With Mild to Moderate Ulcerative Colitis

The purpose of the study is to assess preliminary efficacy, safety, and tolerability of LYS006 in patients with mild to moderate ulcerative colitis and to determine if LYS006 has an adequate clinical profile for further development in this indication.

hematochezia
endoscopy
Novartis Investigative Site
 (8.8 away) Contact site
  • 13 views
  • 12 Sep, 2021
  • +19 other locations
Pivotal Open-label Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

The study is a prospective, randomized controlled phase III trial, to test the efficacy, safety and neurocognitive outcomes of advanced NSCLC patients, following stereotactic radiosurgery (SRS) for 1-10 brain metastases, treated with NovoTTF-100M compared to supportive treatment alone. The device is an experimental, portable, battery operated device for chronic administration …

Loyola University Medical Center
 (18.2 away) Contact site
  • 0 views
  • 19 Sep, 2021
  • +131 other locations
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

This phase III trial studies combination chemotherapy and atezolizumab to see how well it works compared with combination chemotherapy alone in treating patients with stage III colon cancer and deficient deoxyribonucleic acid (DNA) mismatch repair. Drugs used in combination chemotherapy, such as oxaliplatin, leucovorin calcium, and fluorouracil, work in different …

antibiotics
monoclonal antibodies
colon cancer
atezolizumab
antifungal agents
Northwestern Medicine Cancer Center Warrenville
 (1.4 away) Contact site
  • 1047 views
  • 19 Sep, 2021
  • +595 other locations
A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer

This study will test an experimental drug (enfortumab vedotin) alone and with different combinations of anticancer therapies. Pembrolizumab is an immune checkpoint inhibitor (CPI) that is used to treat patients with cancer of the urinary system (urothelial cancer). This type of cancer includes cancer of the bladder, renal pelvis, ureter …

chemoradiation
immune checkpoint inhibitor
pembrolizumab
hearing loss
combinations
Northwestern Medicine Cancer Center - Warrenville / Central DuPage Hospital - Cancer Care
 (1.4 away) Contact site
  • 284 views
  • 19 Sep, 2021
  • +92 other locations